诺和诺德司美格鲁肽的最强对手正式在中国正式商业化上市。 12月25日,澎湃新闻记者注意到,目前多家电商平台已经有礼来葡萄糖依赖性促胰岛素多肽(GIP)/ 胰高糖素样肽-1(GLP-1)受体激动剂替尔泊肽(商品名:穆峰达)的诊疗拿药服务。替尔泊肽的适应证包括糖尿病、减重,目前平台各个商家的价格有所差异,并提示具体价格以最终选择的门店价格为准。 多个电商平台可购礼来替尔泊肽 以某互联网医院商家...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.